「Tuberculosis」の版間の差分
ナビゲーションに移動
検索に移動
Vaccipedia.admin (トーク | 投稿記録) |
Vaccipedia.admin (トーク | 投稿記録) |
||
(同じ利用者による、間の10版が非表示) | |||
1行目: | 1行目: | ||
+ | {{TM menu}} | ||
+ | |||
==History== | ==History== | ||
*Died from or infected by Tb | *Died from or infected by Tb | ||
100行目: | 102行目: | ||
*cardiac tamponade | *cardiac tamponade | ||
*sequele - carcified pericardium | *sequele - carcified pericardium | ||
+ | *very pauci-bacillary and bacterial investigation from pericardiocentesis is very much less sensitive | ||
+ | |||
====intestinal==== | ====intestinal==== | ||
*can mimic Crohn's disease | *can mimic Crohn's disease | ||
161行目: | 165行目: | ||
*Gene Xpert | *Gene Xpert | ||
**Xpert MTB/RIF | **Xpert MTB/RIF | ||
− | **can detect | + | **can detect resistance to rifampicin |
====histopathology==== | ====histopathology==== | ||
181行目: | 185行目: | ||
*cannot distinguish between latent/active/used be treated | *cannot distinguish between latent/active/used be treated | ||
− | ==Treatment | + | ==Treatment== |
*needs prolonged Tx | *needs prolonged Tx | ||
*needs multiple drugs | *needs multiple drugs | ||
195行目: | 199行目: | ||
*2RHZE+4RH | *2RHZE+4RH | ||
− | *2RHZE+4(RH) | + | *2RHZE+4(RH)₃ |
===side effects=== | ===side effects=== | ||
222行目: | 226行目: | ||
*needs 12 months | *needs 12 months | ||
*2RHZE+10RH | *2RHZE+10RH | ||
+ | |||
+ | ===latent TB=== | ||
+ | *some options | ||
+ | |||
+ | ==Management== | ||
+ | ===paradoxical reaction=== | ||
+ | *inflammation after commencing Tx | ||
+ | *problematic in CNS, pericardial | ||
+ | *co-Tx with steroids | ||
+ | **CNS/meningitis,tuberculoma - dexamethasone | ||
+ | **pericardial - predonisolone | ||
+ | |||
+ | ===Directoly Observed Treatment, short course (DOTs)=== | ||
+ | *in high risk stuation | ||
+ | *in homeless/chaotic social circumstance | ||
+ | *in poor adherence/treatment failure | ||
+ | |||
+ | *Dr. Karlos Stybro | ||
+ | |||
+ | ===TB in pregnancy=== | ||
+ | *RHZE are safe | ||
+ | *supplementation with VitB6 (pyridoxine) recommended | ||
+ | **hyperemesis gravidarum | ||
+ | |||
+ | ===TB in breastfeeding=== | ||
+ | *no contraindication | ||
+ | *rule out TB in baby | ||
+ | |||
+ | ===hepatotoxicity=== | ||
+ | *any GI complaint may represent hepatotoxicity | ||
+ | *suspend all TB drugs until lab test revealed | ||
+ | *risk | ||
+ | **co-infection HIV, hepB/C | ||
+ | **other chronic liver disease | ||
+ | **alcohol | ||
+ | **advanced age | ||
+ | *early - 2-3wks, R,H; good prognosis | ||
+ | *late - after 1mo, E; bad prognosis | ||
==Drug-resistant== | ==Drug-resistant== | ||
+ | ===mono-resistant=== | ||
+ | *H-resistant approx. 7% | ||
+ | |||
+ | *primary resistance | ||
+ | **infected by resistant TB | ||
+ | *secondary resistance | ||
+ | ** | ||
+ | |||
+ | ===multi-resistant MDR=== | ||
+ | *resistant to H and R | ||
+ | *risk | ||
+ | **previous Tx | ||
+ | **household contact with MDR | ||
+ | **HIV | ||
+ | *resistance to R is a marker of MDR | ||
+ | **90% of R-resistance strains are also resistant to H → GeneXpert | ||
+ | |||
+ | ===extensively resistant XDR=== | ||
+ | *MDR + fluoroquinolone-resistant and at least one additional group A drug | ||
+ | |||
+ | ===pre-extensively resistant pre-XDR=== | ||
+ | *MDR + fluoroquinolone-resistant |
2021年6月4日 (金) 15:14時点における最新版
Navigation Menu |
General issues of Vaccine | |||||||
---|---|---|---|---|---|---|---|
|
General issues of Travel med. | ||||||||
---|---|---|---|---|---|---|---|---|
|
Immunology | |||||||
---|---|---|---|---|---|---|---|
|
Epi & Stats | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Virus | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
COVID-19 | |||||
---|---|---|---|---|---|
|
Bacteria | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Rickettsia | |||||
---|---|---|---|---|---|
|
Protozoa | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Fungi | |||||||
---|---|---|---|---|---|---|---|
|
Nematode (roundworm) | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Trematode (fluke, distoma) | |||||||
---|---|---|---|---|---|---|---|
|
Cestode (tapeworm) | ||||||
---|---|---|---|---|---|---|
|
Medical Zoology | ||||||||
---|---|---|---|---|---|---|---|---|
|
目次
History
- Died from or infected by Tb
- John Keats (poet)
- George O'well
- Nelson Mandella
- Hippocrates description
- Phthisis (to waste away, consumption)
- Robert Koch found the bacteria 1882
Epidemiology
est. case est. death all form 10mil 1.4mil HIV-ass 0.9 mil 208,000 MDR-Tb ≈558,000 ≈190,000
- 8 countries account for 2/3 of all worldwide Tb
- India
- China
- Indonesia
- the Phillippines
- Pakistan
- Nigeria
- Bangladesh
- South Africa
Transmission
- transmission-influencing factors
- sputum status of index case
- proximity - distance between each other
- time
- susceptibility of person
- [math]\displaystyle{ R_0 \approx r \times c \times d }[/math]
- [math]\displaystyle{ r }[/math] = transmissibility
- to reduce [math]\displaystyle{ r }[/math]
- ealier detection
- rapid commencing of treatment
- reduce aerolization (surgical masks on patients)
- surgical masks on patients reduce infectivity by 56%
- to reduce [math]\displaystyle{ r }[/math]
- [math]\displaystyle{ c }[/math] = susceptibility of contacts
- to reduce [math]\displaystyle{ c }[/math]
- open windows
- Tb airborne transmission risk: windows closed 97%, negative pressure room (ACH12) 39%, windows and doors fully open 33%
- N95 respirator
- ARTs for HIV patients
- open windows
- to reduce [math]\displaystyle{ c }[/math]
- [math]\displaystyle{ d }[/math] = duration of infectivity
- to reduce [math]\displaystyle{ d }[/math]
- treat patients appropriately
- to reduce [math]\displaystyle{ d }[/math]
- [math]\displaystyle{ r }[/math] = transmissibility
Risk factors
- HIV
- malnutrition
- Tb risk inversely correlates with BMI
- diabetes
- diabetes and Tb are syndemic
- diabetes and Tb pathophysiologically exacerbate each other even under treatment condition in terms of hepatotoxicity
- overcrowding
- people per room vs Tb rate per 100,000 (in Canada)
- 0.4-0.6 vs 18.9
- 1.0-1.2 vs 113
- people per room vs Tb rate per 100,000 (in Canada)
- ....
Natural history
- inhalation of M.tb containing droplets
- macrophages phagocytosis
- granuloma + lymphadenopathy
- Ghon complex - primary infection
- 5% local progression/disseminated Tb
- 95% latent Tb
- 10% of latent Tb reactivates in lifetime - secondary Tb
Latent Tb
- 1/3 of the world's population have latent Tb
- modelling approx. 1.7 bil. people
- 10% of those latent Tb people get reactivation in their lifetime
Symptoms
- cough ± sputum ± hemoptysis > 2weeks
- fever
- malaise
- weight loss
Various presentations
pulmonary
- 80-85% of TB diagnosis are pulmonary
extra-pulmonary
lymphadenitis - hilar/other
- cold abscess
- more common in cervical and hilar
- possibly in axillar, inguinal and abdominal
- hilar adenitis DDx - sarcoidosis, lymphoma, histoplasmosis
pleural
- usually uni-lateral
- effusion high LDH, high protein, high lymphocyte
pericardial
- cardiac tamponade
- sequele - carcified pericardium
- very pauci-bacillary and bacterial investigation from pericardiocentesis is very much less sensitive
intestinal
- can mimic Crohn's disease
- most common in ileocecal
meningitis
- often involves 3rd and 6th cranial nerves
- meningeal irritation signs often unaccompanied
cerebral tuberculoma
- DDx primary CNS lymphoma
Pott's disease (vertebral destruction due to TB)
- kyphosis, gibbus formation
- sometimes extends to psoas muscle abscess;
arthritis
- synovial fluid does not necessarily contains enough TB bacteria; fluid culture may miss diagnosis
- IGRA could be clue
skin
- erythema nodosum
- DDx - TB, cryptococcal, sarcoidosis, UC, oral contraceptive, ≈50% idiopathic
- lupus vulgaris
miliary TB
- massive lymphohematogenous dissemination
- nodules diameter <10mm
- liver
- spleen
- bone marrow
- lungs
- pulmonary miliary TB easily missed by chest X-ray
- meninges
Diagnosis
baseline investigation
blood
- full blood count
- clues for TB - leukopenia, anemia, thrombocytopenia
- liver enzyme, renal function, electrolyte
- for baseline to monitor Tx side effect or to adjust dose
- diabetes
- co-infection
- HIV
- Hep B - HBsAg
- Hep C - HCV-Ab
imaging
- chest X-ray
- other targeted imaging
microbiological
smear/microscopy
- Ziehl-Neelsen of sputum
- positive smear needs cavitation
- children and HIV-positive tend not to cavitate
- specificity 98%
- fluorescent
culture - 4-8weeks
- culture is definitive/reference standard
- Lowenstein-Jensen medium
- liquid medium 3 weeks
PCR TB DNA
- Gene Xpert
- Xpert MTB/RIF
- can detect resistance to rifampicin
histopathology
- tissue biopsy
- caseating granuloma
- multinucleated giant cells with nuclei arranged like a horseshoe
- caseating granuloma
urinary LAM antigen detection
- mycobacterial cell wall glycolipid antigen lipoarabinomannan (LAM)
- marker of active TB
- specificity 98%
- sensitivity 40-70%
Manteau text/tuberculin skin test (TST)
- low value for diagnosis
Interferon gamma release assay (IGRA)
- T-SPOT/Quantiferon(QFT)
- cannot distinguish between latent/active/used be treated
Treatment
- needs prolonged Tx
- needs multiple drugs
1st line target
- cell wall synthesis
- H - isoniazid (isoniotinic adid hydrozide)
- E - ethanbutol
- DNA synthesis
- R - rifampicin
- ?
- Z - pyrazinamide
- 2RHZE+4RH
- 2RHZE+4(RH)₃
side effects
- hepatotoxicity - H, R, Z
- ocular toxicity - E
- peripheral neuropathy - H
- add vitamin B6 (pyridoxin)
- gout - Z
- fever - Z
- lupus - H
- drug interaction related to CYP 450P - R
- carbamazepine
- oral contraceptive
- methadone
interrupted Tx
- interrupted during intensive phase
- interrupted for > 14 days - re-Tx from the beggining
- interrupted for < 14 days - continue
- during continuing phase
spinal/bone TB
- needs 9 months
TB meningitis
- needs 12 months
- 2RHZE+10RH
latent TB
- some options
Management
paradoxical reaction
- inflammation after commencing Tx
- problematic in CNS, pericardial
- co-Tx with steroids
- CNS/meningitis,tuberculoma - dexamethasone
- pericardial - predonisolone
Directoly Observed Treatment, short course (DOTs)
- in high risk stuation
- in homeless/chaotic social circumstance
- in poor adherence/treatment failure
- Dr. Karlos Stybro
TB in pregnancy
- RHZE are safe
- supplementation with VitB6 (pyridoxine) recommended
- hyperemesis gravidarum
TB in breastfeeding
- no contraindication
- rule out TB in baby
hepatotoxicity
- any GI complaint may represent hepatotoxicity
- suspend all TB drugs until lab test revealed
- risk
- co-infection HIV, hepB/C
- other chronic liver disease
- alcohol
- advanced age
- early - 2-3wks, R,H; good prognosis
- late - after 1mo, E; bad prognosis
Drug-resistant
mono-resistant
- H-resistant approx. 7%
- primary resistance
- infected by resistant TB
- secondary resistance
multi-resistant MDR
- resistant to H and R
- risk
- previous Tx
- household contact with MDR
- HIV
- resistance to R is a marker of MDR
- 90% of R-resistance strains are also resistant to H → GeneXpert
extensively resistant XDR
- MDR + fluoroquinolone-resistant and at least one additional group A drug
pre-extensively resistant pre-XDR
- MDR + fluoroquinolone-resistant